Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer February 20, 2018December 14, 2022 Arthur N. Brodsky, PhD
Immuno-Oncology 360°: Taking Immunotherapy to the Next Level February 6, 2018December 14, 2022 Arthur N. Brodsky, PhD
How Man’s Best Friend Could Help Us Cure Cancer January 22, 2018December 14, 2022 Arthur N. Brodsky, PhD